Home LiteratureArticle Details
PMID: 15557320 Published · ppublish English Journal Article

Evidence that monoclonal antibodies directed against the integrin beta subunit plexin/semaphorin/integrin domain stimulate function by inducing receptor extension.

The Journal of biological chemistry ·Vol. 280 ·No. 6 ·2005-02-11 ·Pages 4238-46

Mould AP, Travis MA, Barton SJ, Hamilton JA, Askari JA, Craig SE, Macdonald PR, Kammerer RA, Buckley PA, Humphries MJ

Abstract

The overall structure of integrins is that of a ligand-binding head connected to two long legs. The legs can exhibit a pronounced bend at the "knees," and it has been proposed that the legs undergo a dramatic straightening when integrins transit from a low affinity to a high affinity state. The knee region contains domains from both alpha and beta subunits, including the N-terminal plexin/semaphorin/integrin (PSI) domain of the beta subunit. The role played by the knee domains in the regulation of integrin-ligand binding is uncertain. Here we show that: (i) monoclonal antibodies (mAbs) N29 and 8E3 have epitopes in the beta(1) subunit PSI domain and stimulate ligand binding to alpha(5)beta(1); (ii) N29 and 8E3 cause long range conformational changes that alter the ligand binding activity of the head region; (iii) the stimulatory action of these mAbs is dependent on the calf-1 domain, which forms part of the alpha subunit knee; and (iv) the epitopes of 8E3 and N29 map close to the extreme N terminus of the PSI and are likely to lie on the side of this domain that faces the alpha subunit. Taken together, our data suggest that the binding of these mAbs results in a levering apart of the PSI and calf-1 domains, and thereby causes the alpha and beta subunit knees to separate. Several major inferences can be drawn from our findings. First, the PSI domain appears to form part of an interface with the alpha subunit that normally restrains the integrin in a bent state. Second, the PSI domain is important for the transduction of conformational changes from the knee to head. Third, unbending is likely to provide a general mechanism for control of integrin-ligand recognition.

MeSH Terms
Animals Antibodies, Monoclonal/chemistry CHO Cells Cell Adhesion Molecules/chemistry Cricetinae Enzyme-Linked Immunosorbent Assay Epitope Mapping Epitopes/chemistry Genetic Vectors Humans Integrin alpha5beta1/metabolism Integrin beta Chains/chemistry Integrins/chemistry Ligands Mutagenesis, Site-Directed Nerve Tissue Proteins/chemistry Placenta/metabolism Protein Binding Protein Conformation Protein Structure, Tertiary Recombinant Proteins/chemistry Semaphorins/chemistry
Chemicals
Antibodies, Monoclonal Cell Adhesion Molecules Epitopes Integrin alpha5beta1 Integrin beta Chains Integrins Ligands Nerve Tissue Proteins Recombinant Proteins Semaphorins plexin
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Mould A Paul
Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom. [email protected]
Travis Mark A
Barton Stephanie J
Hamilton Jennifer A
Askari Janet A
Craig Susan E
Macdonald Philip R
Kammerer Richard A
Buckley Patrick A
Humphries Martin J
References (46)
46 references, click to expand
  1. A novel adaptation of the integrin PSI domain revealed from its crystal structure.
    J Biol Chem. 2004 Sep 24;279(39):40252-4 PMID: 15299032
  2. Regulation of integrin function through conformational complexity: not simply a knee-jerk reaction?
    Curr Opin Cell Biol. 2004 Oct;16(5):544-51 PMID: 15363805
  3. Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the beta 1 subunit.
    FEBS Lett. 1995 Apr 17;363(1-2):118-22 PMID: 7537221
  4. Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit.
    J Biol Chem. 1995 May 19;270(20):11947-54 PMID: 7538128
  5. Monoclonal antibody 9EG7 defines a novel beta 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium.
    J Biol Chem. 1995 Oct 27;270(43):25570-7 PMID: 7592728
  6. Regulation of integrin alpha 5 beta 1-fibronectin interactions by divalent cations. Evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+.
    J Biol Chem. 1995 Nov 3;270(44):26270-7 PMID: 7592835
  7. Control of beta1 integrin function. Localization of stimulatory epitopes.
    J Biol Chem. 1996 Feb 9;271(6):3046-51 PMID: 8621699
  8. The inhibitory anti-beta1 integrin monoclonal antibody 13 recognizes an epitope that is attenuated by ligand occupancy. Evidence for allosteric inhibition of integrin function.
    J Biol Chem. 1996 Aug 23;271(34):20365-74 PMID: 8702772
  9. Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit.
    J Biol Chem. 1997 Jul 11;272(28):17283-92 PMID: 9211865
  10. Integrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the beta1 integrin chain.
    J Biol Chem. 1998 Apr 3;273(14):7981-7 PMID: 9525896
  11. Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1.
    Biochem J. 1998 May 1;331 ( Pt 3):821-8 PMID: 9560310
  12. The 'ligand-induced conformational change' of alpha 5 beta 1 integrin. Relocation of alpha 5 subunit to uncover the beta 1 stalk region.
    J Cell Sci. 1998 Jun;111 ( Pt 12):1759-66 PMID: 9601105
  13. Localisation of a novel adhesion blocking epitope on the human beta 1 integrin chain.
    Cell Adhes Commun. 1998 Jun;5(4):257-71 PMID: 9762467
  14. Domains in plexins: links to integrins and transcription factors.
    Trends Biochem Sci. 1999 Jul;24(7):261-3 PMID: 10390613
  15. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation.
    Nat Struct Biol. 2002 Apr;9(4):282-7 PMID: 11896403
  16. Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitors.
    Semin Thromb Hemost. 2004 Oct;30(5):569-77 PMID: 15497099
  17. Probing chemical and conformational differences in the resting and active conformers of platelet integrin alpha(IIb)beta(3).
    J Biol Chem. 2000 Mar 10;275(10):7249-60 PMID: 10702295
  18. Association of the membrane proximal regions of the alpha and beta subunit cytoplasmic domains constrains an integrin in the inactive state.
    J Biol Chem. 2001 May 4;276(18):14642-8 PMID: 11279101
  19. Amino acid residues in the PSI domain and cysteine-rich repeats of the integrin beta2 subunit that restrain activation of the integrin alpha(X)beta(2).
    J Biol Chem. 2001 Mar 9;276(10):6922-9 PMID: 11096074
  20. Generation of a minimal alpha5beta1 integrin-Fc fragment.
    J Biol Chem. 2001 Sep 21;276(38):35854-66 PMID: 11389148
  21. Crystal structure of the extracellular segment of integrin alpha Vbeta3.
    Science. 2001 Oct 12;294(5541):339-45 PMID: 11546839
  22. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.
    Science. 2002 Apr 5;296(5565):151-5 PMID: 11884718
  23. Integrin activation involves a conformational change in the alpha 1 helix of the beta subunit A-domain.
    J Biol Chem. 2002 May 31;277(22):19800-5 PMID: 11893752
  24. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes.
    Blood. 2002 Sep 15;100(6):2094-101 PMID: 12200372
  25. A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face.
    Cell. 2002 Sep 6;110(5):587-97 PMID: 12230976
  26. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling.
    Cell. 2002 Sep 6;110(5):599-11 PMID: 12230977
  27. Integrins: bidirectional, allosteric signaling machines.
    Cell. 2002 Sep 20;110(6):673-87 PMID: 12297042
  28. Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand.
    Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2403-8 PMID: 12604783
  29. An unraveling tale of how integrins are activated from within.
    Trends Pharmacol Sci. 2003 Apr;24(4):192-7 PMID: 12707006
  30. Mapping functional residues onto integrin crystal structures.
    Curr Opin Struct Biol. 2003 Apr;13(2):236-43 PMID: 12727518
  31. Conformational changes in the integrin beta A domain provide a mechanism for signal transduction via hybrid domain movement.
    J Biol Chem. 2003 May 9;278(19):17028-35 PMID: 12615914
  32. Integrin structure: heady advances in ligand binding, but activation still makes the knees wobble.
    Trends Biochem Sci. 2003 Jun;28(6):313-20 PMID: 12826403
  33. New insights into the structural basis of integrin activation.
    Blood. 2003 Aug 15;102(4):1155-9 PMID: 12714499
  34. Structure of the semaphorin-3A receptor binding module.
    Neuron. 2003 Aug 14;39(4):589-98 PMID: 12925274
  35. Therapeutic antagonists and conformational regulation of integrin function.
    Nat Rev Drug Discov. 2003 Sep;2(9):703-16 PMID: 12951577
  36. Structure of integrin alpha5beta1 in complex with fibronectin.
    EMBO J. 2003 Sep 15;22(18):4607-15 PMID: 12970173
  37. Integrin avidity regulation: are changes in affinity and conformation underemphasized?
    Curr Opin Cell Biol. 2003 Oct;15(5):547-56 PMID: 14519389
  38. FRET detection of cellular alpha4-integrin conformational activation.
    Biophys J. 2003 Dec;85(6):3951-62 PMID: 14645084
  39. Role of ADMIDAS cation-binding site in ligand recognition by integrin alpha 5 beta 1.
    J Biol Chem. 2003 Dec 19;278(51):51622-9 PMID: 14532288
  40. Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions.
    Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2333-8 PMID: 14983010
  41. Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfides.
    J Biol Chem. 2004 Mar 12;279(11):10215-21 PMID: 14681220
  42. Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction.
    Immunity. 2004 Apr;20(4):393-406 PMID: 15084269
  43. Novel activating and inactivating mutations in the integrin beta1 subunit A domain.
    Biochem J. 2004 Jun 1;380(Pt 2):401-7 PMID: 14967067
  44. Interaction of filamin A with the integrin beta 7 cytoplasmic domain: role of alternative splicing and phosphorylation.
    FEBS Lett. 2004 Jul 2;569(1-3):185-90 PMID: 15225631
  45. Conformational regulation of alpha 4 beta 1-integrin affinity by reducing agents. "Inside-out" signaling is independent of and additive to reduction-regulated integrin activation.
    J Biol Chem. 2004 Jul 30;279(31):32435-43 PMID: 15166232
  46. Insights into function of PSI domains from structure of the Met receptor PSI domain.
    Biochem Biophys Res Commun. 2004 Aug 13;321(1):234-40 PMID: 15358240
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2005-02-11
Epub
2004-00-22
Pages
4238-46
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC3328395
Subset
IM
Grants
Wellcome Trust · United Kingdom
Wellcome Trust · 074941 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]